All In Biotech

Drug Trial Radar · NCT05277896

Randomized Trial of Sedative Choice for Intubation

The Randomized Trial of Sedative Choice for Intubation

Last checked: Nov 20, 2026Latest source record: Mar 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,367 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,367

Actual

Start

Apr 6, 2022

Primary completion

Sep 6, 2025

Study completion Sep 6, 2025

Sponsor

Lead sponsor
Vanderbilt University Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Patient-Centered Outcomes Research Institute
First posted
Mar 14, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Among critically ill adults undergoing emergency tracheal intubation, one in five experience hypotension, cardiac arrest, or death. The sedatives used to rapidly induce anesthesia for emergency tracheal intubation have been hypothesized to effect cardiovascular complications and patient outcomes, but the optimal sedative medication for intubation of critically ill adults remains unknown. Ketamine and etomidate are the two most commonly used sedatives during intubation of critically ill adults. Data from a randomized clinical trial are urgently needed to determine the effect of ketamine versus etomidate on cardiovascular complications and clinical outcomes of emergency tracheal intubation.

Conditions

  • Acute Respiratory Failure

Interventions

  • KetamineDrug

    Intravenous ketamine as the sedative for induction of anesthesia during emergency tracheal intubation

  • EtomidateDrug

    Intravenous etomidate as the sedative for induction of anesthesia during emergency tracheal intubation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause, 28-day, In-hospital MortalityTime frame: 28 days

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • UAB Hospital

    Birmingham, Alabama

  • University of Colorado Denver

    Aurora, Colorado

  • Denver Health Medical Center

    Denver, Colorado

  • Hennepin County Medical Center

    Minneapolis, Minnesota

  • Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina

  • Vanderbilt University Medical Center

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.